XM does not provide services to residents of the United States of America.

Indian stocks to stay flattish for 3 months as earnings, valuations weigh, says Goldman



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Indian stocks to stay flattish for 3 months as earnings, valuations weigh, says Goldman</title></head><body>

Nov 21 (Reuters) -Indian equities are likely to remain rangebound over the next three months, following their recent slide into correction territory after the worst earnings season in four years and nursing still-high valuations, Goldman Sachs said.

The Wall Street brokerage, which remains tactically "marketweight" on Indian equities, expects the benchmark Nifty 50 .NSEI to hit 24,000 points in the next three months, implying a gain of a little under 3% from current levels.

Still, that is a reversal from last month when it had predicted the Nifty would fall about 1% to around 24,500 in three months.

Since that prediction, the Nifty and the BSE Sensex .BSESN have slipped into the correction territory, having fallen more than 10% from their respective all-time highs on Sept. 27 due to record foreign outflows and underwhelming corporate earnings.

"We expect the market to remain rangebound over the next 3 months and for a back-loaded recovery as growth picks up," Goldman analysts said in a note published late on Tuesday.

They expect the Nifty to hit 27,000 in 12 months, implying a nearly 16% gain from current levels and surpassing its record high of 26,277.35.

However, Goldman said Indian equities run the risk of further de-rating as, despite the recent slide, valuations still remain above a 'fair-value' estimate of 21 times forward earnings (PE).

"Valuations have de-rated 8% after the recent pullback, but still trade at nearly 23x forward PE for MSCI India, which is 1.4 standard deviation above its 10-year mean."

The MSCI India index .MIIN00000PIN is also in correction, or down more than 10% from its record high.

Goldman expects Indian companies to post 13%-16% earnings growth over 2025, which is factored into their long-term Nifty target.

For the July-September quarter, around half of the 50 firms on the Nifty have beaten analysts' estimates, the lowest since 20% of companies topped estimates in the March 2020 quarter at the start of the COVID-19 pandemic, per data compiled by LSEG.



Reporting by Shubham Batra in Bengaluru; Editing by Savio D'Souza

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.